 |
|
|
|
|
|
|
| File | Fileinfo | Date | Filesize | |||
 | | Download PDF | | 25.04.08 | | 60 KB |
Resolutions of the 2008 AGM
West Chester (PA), USA, April 25, 2008
The 9th Annual General Meeting of Shareholders was held on April 24, 2008 at 4 pm at the Landhaus in Solothurn.
76,957,091 of the 118,699,793 issued and outstanding shares were represented at the AGM. The 186 shareholders attending the meeting represented 64.8% of the total capital.
The following resolutions were passed with few dissenting votes and abstentions:
Agenda item 3
The shareholders approved the report on the financial year, the annual accounts and the consolidated accounts for 2007.
Agenda item 4
The shareholders took note of a dividend of CHF 0.90 per share of common stock. The dividend will be paid out on April 30, 2008.
Agenda item 5
The shareholders elected Messrs Dr. Roland Brönnimann and Robert Bland as well as Mrs Amy Wyss to the Board of Directors as Class III Directors for a term of three years.
Agenda item 6
The shareholders ratified the selection of Ernst & Young as auditors of Synthes, Inc. for 2008.
The meeting was closed at 5.15 pm.
Synthes: A leading medical device company
Synthes is a leading global medical device company. We develop, produce and market instruments, implants and biomaterials for the surgical fixation, correction and regeneration of the human skeleton and its soft tissues.
Image Bank
A selection of product and company images can be found at
http://www.synthes.com/html/Media-Corner.7325.0.html?&L=0.
For further information please contact
Gilgian Eisner, Investor Relations, Synthes, Inc.
Phone +41 32 720 47 45, Fax +41 32 720 48 11,
e-mail: ir.info@synthes.com